Toronto Dominion Bank’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,056
| Closed | -$1K | – | 1314 |
|
|
2022
Q3 | $1K | Buy |
1,056
+653
| +162% | +$618 | ﹤0.01% | 1257 |
|
|
2022
Q2 | $0 | Hold |
403
| – | – | ﹤0.01% | 2025 |
|
|
2022
Q1 | $1K | Sell |
403
-561
| -58% | -$1.39K | ﹤0.01% | 1358 |
|
|
2021
Q4 | $3K | Buy |
964
+664
| +221% | +$2.07K | ﹤0.01% | 1421 |
|
|
2021
Q3 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 1349 |
|
|
2021
Q1 | – | Sell |
-192
| Closed | -$1K | – | 1542 |
|
|
2020
Q4 | $1K | Buy |
192
+15
| +8% | +$78 | ﹤0.01% | 1263 |
|
|
2020
Q3 | $1K | Sell |
177
-132
| -43% | -$746 | ﹤0.01% | 1138 |
|
|
2020
Q2 | $1K | Sell |
309
-85
| -22% | -$275 | ﹤0.01% | 1137 |
|
|
2020
Q1 | $2K | Buy |
+394
| New | +$2K | ﹤0.01% | 1072 |
|
|
2019
Q4 | – | Sell |
-701
| Closed | -$5K | – | 1240 |
|
|
2019
Q3 | $5K | Buy |
701
+607
| +646% | +$4.33K | ﹤0.01% | 1009 |
|
|
2019
Q2 | $1K | Buy |
94
+57
| +154% | +$607 | ﹤0.01% | 1078 |
|
|
2019
Q1 | $0 | Sell |
37
-130
| -78% | – | ﹤0.01% | 1292 |
|
|
2018
Q4 | $0 | Buy |
+167
| New | – | ﹤0.01% | 1262 |
|
|
2017
Q4 | – | Sell |
-199
| Closed | -$2K | – | 1084 |
|
|
2017
Q3 | $2K | Buy |
+199
| New | +$2K | ﹤0.01% | 957 |
|